Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

BloomWell Rx Tirzepatide Review: Cost, GIP Menu & Honest Verdict (2026)

An honest 2026 review of BloomWell Rx for compounded tirzepatide — a GLP-1 vs GLP-1/GIP menu, LegitScript certification, nationwide shipping, and the caveats.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Found

Established, physician-designed weight care with a broad formulary — real brand-name Zepbound/Mounjaro alongside compounded tirzepatide, paired with coaching.

$289/mo m2m ($169/mo on 12-mo prepay)

Check Found availability

BloomWell Rx is a nationwide compounded-GLP-1 telehealth service that puts single-agonist GLP-1 (semaglutide) and dual GIP/GLP-1 (tirzepatide) side by side on the same menu, along with a wider wellness catalog. This review covers what BloomWell Rx is, what it dispenses, the compounded-versus-brand distinction, its pricing, and the caveats — including one place our live check corrected a fact in the ranking we track. Every fact here comes from the company's own published program, checked directly against joinbloomrx.com.

What BloomWell Rx is

BloomWell Rx is a fully online telehealth service offering compounded GLP-1 therapy after a free initial visit, partnering with independent licensed physicians and U.S.-licensed pharmacies for prescribing and fulfillment (the specific compounding pharmacy is not named on the site). It says it serves the entire country. Medications ship contact-free, requiring no signature. Beyond weight care, BloomWell Rx sells a broader wellness menu — NAD+, glutathione, hormone therapies, and sexual-health medications — and separately lists branded alternatives (Zepbound, Wegovy, Foundayo) alongside its compounded tier. Importantly, the site displays a LegitScript approval seal — a correction worth flagging: a prior check of the ranking we track had recorded BloomWell Rx as not LegitScript-certified, and our live check found that to be out of date; the seal is visible on the homepage as of this review.

The compounded-vs-brand question

Two very different products share the name tirzepatide:

  • Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
  • Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

BloomWell Rx's core tirzepatide offering is compounded, marketed as a "Personalized GLP-1/GIP" tier distinct from its single-agonist "Personalized GLP-1" (semaglutide) tier — a genuinely useful menu structure if you're trying to decide between the two mechanisms, which we cover in depth in tirzepatide vs semaglutide. It separately lists branded Zepbound as an alternative pathway. That compounded-vs-brand distinction matters more in 2026, now that the enforcement discretion permitting routine large-scale compounding has ended; the full timeline is in our guide to whether compounded tirzepatide is still legal in 2026.

§ BloomWell Rx — GLP-1 vs GLP-1/GIP Menu

ItemBloomWell RxNote
Personalized GLP-1 (semaglutide)From $199/month"Starts at"; final cost varies by dose
Personalized GLP-1/GIP (tirzepatide)From $249/month"Starts at"; final cost varies by dose
LegitScript certifiedYesVerified; corrects prior roster entry
Coverage areaNationwideVerified
Prices on joinbloomrx.com as 'starts at' figures, not flat quotes. LegitScript certification correcting a prior roster entry that recorded BloomWell Rx as uncertified. Brand Zepbound via LillyDirect runs ~$299–$449/month (vials, in effect since December 1, 2025).

What BloomWell Rx costs in 2026

Per the live homepage, the "Personalized GLP-1" (semaglutide) tier starts at $199/month, and the "Personalized GLP-1/GIP" (tirzepatide) tier starts at $249/month. The site does not break out what the starting-dose figure includes versus what a maintenance dose costs, and "starts at" pricing means your actual monthly cost depends on the dose and plan you land on after the intake. NAD+ and glutathione are each listed separately at $249/month.

For context, LillyDirect sells brand Zepbound self-pay vials at roughly $299–$449/month depending on dose (prices in effect since December 1, 2025; 28-day supply) — the branded alternative BloomWell Rx itself lists alongside its compounded tier. For the full cash-price picture, see our Zepbound cost and savings guide.

How the care model holds up

BloomWell Rx's strengths are real: a LegitScript-certified operation (correcting an out-of-date entry in the ranking we track), a genuinely useful GLP-1 vs GLP-1/GIP menu that puts the mechanistic choice in front of you rather than defaulting to one drug, nationwide availability, and contact-free, signature-free shipping. The trade-offs: pricing is "starts at," not flat, so the number on the homepage isn't necessarily what you'll pay; the compounding pharmacy partner is not named, only described as "U.S.-licensed"; and the operating medical entity behind the clinical side isn't clearly named either (the site presents primarily as a storefront). As with any GLP-1 service, confirm your all-in monthly cost in writing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

BloomWell Rx is worth a look if you want a LegitScript-certified, nationwide compounded program that lets you compare GLP-1 against GLP-1/GIP on one menu, alongside a broader wellness catalog — and you're comfortable that the "starts at" price isn't a flat quote and the compounding pharmacy isn't named. If you want the same dual-molecule menu with a named pharmacy relationship, compare it against our yourEra review; if you want flat, fully transparent compounded pricing, see our tru Weight Loss review. See our best tirzepatide providers ranking and tirzepatide vs semaglutide breakdown.

Frequently asked questions

How much does tirzepatide cost through BloomWell Rx?

The "Personalized GLP-1/GIP" (tirzepatide) tier starts at $249/month, and the single-agonist "Personalized GLP-1" (semaglutide) tier starts at $199/month, per the live homepage. Both are "starts at" figures — your final monthly cost depends on the dose and plan you land on after the intake, so confirm the all-in number before committing.

Is BloomWell Rx LegitScript certified?

Yes, as of this review BloomWell Rx displays a LegitScript approval seal on its homepage. A prior check of the ranking we track had recorded it as not certified — our live check found that out of date, which is exactly why we re-verify rather than reuse an old fact.

Is BloomWell Rx's tirzepatide compounded or brand?

The core tirzepatide offering is compounded, sold as a "Personalized GLP-1/GIP" tier. BloomWell Rx separately lists branded alternatives, including Zepbound, alongside its compounded menu, so both pathways exist depending on what you select.

Should I choose GLP-1 or GLP-1/GIP on BloomWell Rx's menu?

That is the tirzepatide-vs-semaglutide question, and the head-to-head trial data favors the dual GIP/GLP-1 agonist (tirzepatide) for both glycemic control and weight loss where the two have been tested directly against each other — see our full breakdown in tirzepatide vs semaglutide. It is a decision to make with a prescriber who knows your history, not from a menu alone.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.. New England Journal of Medicine. PMID: 34170647. https://pubmed.ncbi.nlm.nih.gov/34170647/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.